Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
State University at Albany to Build R&D Center
The State University at Albany's Center of Excellence in Nanoelectronics will expand with a massive $400-million research and development center. Created by an international consortium of computer chip manufacturers, the site will employ 250 researchers engaged in 300-millimeter chip development. The state of New York will contribute $210-million for construction, equipment, and specialized tools.
DPT Labs Builds for R&D in San Antonio
DPT Laboratories Ltd. of San Antonio, a developer, manufacturer, packager and distributer of over-the-counter and prescription skin-care products for pharmaceutical companies, is in the process of completing a $5-million, 32,000-sf R&D facility housing additional chemistry labs and accommodating 75 scientists. The building will both support DPT's contract manufacturing operations, as well as provide expansion space for the company's live-cell therapy research.
FDIC Expands Arlington Campus
The Federal Deposit Insurance Corp. (FDIC) has chosen Ai, a District of Columbia architectural firm, to design a 422,000-sf office expansion at its 370,000-sf Virginia Square campus. The $111-million project will more than double the FDIC's Arlington facilities and will replace four leased D.C. offices.
University of Texas Plans Austin Pharmacy Building Renovation
The University of Texas in Austin recently awarded Watkins Hamilton Ross Architects (WHR) the contract to provide professional services for Phase One of the Pharmacy Building renovation. The 60,000-gsf Pharmacy Building was originally constructed in 1952 and is considered a historically relevant building by the University. The renovation program, including a project budget, should be finalized by the end of October. Upon funding approval, WHR will begin the design process.
Genencor to Build Clinical Manufacturing Facility in Rochester
Genencor of Palo Alto, Calif., will build a 22,000-sf clinical manufacturing facility in Rochester, N.Y., home of the company's global bioproducts business and manufacturing headquarters and a pilot-scale manufacturing plant. The new facility will manufacture human therapeutics. Included in the expansion is a $10-million facility slated to open in 2004 that will produce material for clinical trials. Two additional 20,000-sf buildings are planned for the site in the future.